{
  "ptid_time": "012_S_4849_2013-08-26",
  "img_path": "/data/qiuhui/data/adni/images/012_S_4849/2013-08-26/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 16,976 mm³, 24.0% below the reference mean. With a Z-score of -0.60 (27.4th percentile), this represents normal volume ; hippocampal volume measures 6,413 mm³, 16.5% below the reference mean. With a Z-score of -1.86 (3.2th percentile), this represents moderate atrophy; whole brain volume measures 947,190 mm³, 8.0% below the reference mean. With a Z-score of -0.99 (16.1th percentile), this represents normal volume ; entorhinal cortex volume measures 3,095 mm³, 20.5% below the reference mean. With a Z-score of -1.59 (5.6th percentile), this represents moderate atrophy; fusiform gyrus volume measures 17,570 mm³, 3.5% below the reference mean. With a Z-score of -0.40 (34.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 16,515 mm³, 19.5% below the reference mean. With a Z-score of -1.73 (4.1th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 66.9 years. Gender is Female. Education: 18 years. MMSE: 29.0. MoCA: 24.0. Logical Memory: 9.0. APOEε4 alleles: 2.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate atrophy in the hippocampus, entorhinal cortex, and middle temporal gyrus—key regions affected in Alzheimer's disease. Despite normal MMSE (29/30), the MoCA (24/30) suggests mild cognitive impairment, and the presence of two APOE4 alleles increases AD risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer’s given biomarker profile).  \n\n**Confidence:** **Medium** (high for neurodegeneration, but clinical symptoms are still mild).  \n\n*Note:* If CSF or amyloid PET confirms Aβ pathology, progression to dementia is highly likely. Current cognitive scores align with MCI, but the atrophy pattern is concerning for early AD.",
  "timestamp": "2025-07-25T23:16:39.851849"
}